" class="no-js "lang="en-US"> Fundraising Archives - Medtech Alert
Sunday, March 03, 2024

Sort by:


Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program

Auxilius Pharma has consolidated its funding of $1 Million for developing its lead asset, AUX-001, […]

Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases

Kate Therapeutics, a next-generation gene therapy company, today emerged from stealth mode with a $51 […]

SciTech Development Raises $2.73 Million in Oversubscribed Funding Round to Advance Clinical Trials for Cancer Treatment

SciTech Development has announced it has closed a $2.73M funding round, led by several prominent […]

Eureka Therapeutics Awarded $10.6 Million CIRM Grant to Support Clinical Trial of ARTEMIS® T-Cell Therapy in Pediatric Liver Cancer

Eureka Therapeutics, a clinical-stage biotechnology company developing novel T-cell therapies to treat cancer, today announced […]

RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications

RxLightning, creator of the industry’s first comprehensive platform for streamlining specialty medication access and affordability, […]

ITM Announces €255m Investment Round, Plans to Advance Radiopharmaceutical Pipeline and to Expand Radioisotope Production Capacities

ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, has announced an equity […]

VaxEquity and CPI Announces Innovate UK Grant to Accelerate Next Generation RNA Vaccines and Therapeutics

VaxEquity, developing transformative RNA vaccines and therapeutics based on its next-generation self-amplifying RNA (saRNA) platform, […]

Cytovation Raises $8 Million in Series A Extension Financing Round for Clinical Advancement of CyPep-1, a First-in-class Targeted Tumor Membrane Immunotherapy

Cytovation ASA, a clinical-stage immune-oncology company focused on the development of its first-in-class targeted tumor […]

Amplo Biotechnology Secures Fast Track STTR Funding for AMP-201, a Promising Gene Therapy Targeting Collagen Q Deficiency

Amplo Biotechnology, a leading US-based biotech company dedicated to developing innovative AAV-based gene therapy for […]

ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth

ElevateBio, a technology-driven company focused on powering the creation of life-transforming cell and gene therapies, […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more